上海徽锐生物科技有限公司 China

we are a company focusing on the research and development of new drug
Website:
www.aitectt.cn
Headquartner in China
Biotech/Pharma Category
Service Description
医疗技术 Medical technologies: use ai to empower drug discovery
shen yuli
GM 

丹麦科技创业中心 China

Partnership between Ministry of Foreign Affair and Ministry of Higher Education and Science of Denmark. Help danish high-tech companies and research instututes to enter Chinese market and find Chinese collaborators
昱 祁
创新合作官员 
Functionality

凯因科技 China

Kawin Technology is a Chinese biopharma engaging in liver disease and virus-related disease. 
The turnover in 2019 is over 800 million RMB (115 millon USD). 
We are now in IPO process and projected to be listed in China this year. 

What we are looking for:
Antivirals and liver disease: early staged in-licensing  
Technical collaboration, out-licensing

Headquartner in China
Slides Deck
(jpg, 321.13KB)
Yu Cai
BD Head 
Functionality

华大基因 China

生物科技公司
Website:
Www.genomics.cn
Headquartner in China
Biotech/Pharma Category
Service Description
诊断产品 Diagnostic products
刘 冬媛
业务发展副总监 

华润医药集团 China

We are the flagship subsidiary of China Resources Group, engaging in the research and development, manufacturing, distribution and retail of a broad range of pharmaceutical and healthcare products.In 2018, our total revenue is HK$ 189.7 billion.
Currently CR Pharma Group is one of the TOP 3 pharmacetucial group in China, and our core competences is capabilities are marketing&sales(3000+ Sales Reps for RX and 3000+ Sales Reps for OTC and healthcare products, local Regulatory Affairs(Dedicated RA team), and great manufacturing facilities(40+ manufacturing sites in China, including API and finished products of all dosage forms, 4 sites are approved by US FDA and EMEA).
As a listed company in HK, CR Pharma has estalished consodiated business reputation in healtcare industry and capital market. And currently, nearly all top 50 MNC pharmacetical companies are our business partner in China, and business scope includes JV, Licensing, Commercial Distribution.
Website:
www.crpharm.com
Looking for
Headquartner in China
旭 刘
高级经理 
Functionality

华润双鹤药业 China

央企,从事药品研发,生产,销售,产品超过300个,2019年营业收入将近100亿元,共有400人的研发团队,全国分布19个生产基地,销售网络遍布全国各省,销售团队超过2500人。希望寻找高壁垒仿制药,高端技术平台,505b2,创新化药,生物药&生物类似物的合作机会,合作方式灵活。
怡 李
BD经理 

康宏耀源(天津)技术有限公司 China

The project focuses on the research and development of anti-tumor photosensitizing drugs for photodynamic therapy, creating a research and development technology platform for photosensitizing drugs, and conducting clinical development and transformation of anti-tumor photosensitizing drugs. The new anti-tumor photosensitizer drugs developed by our team exhibited excellent tumor enrichment and high efficacy of photodynamic therapy. They have great potential for clinical development and application.
Website:
NA
Looking for
Headquartner in China
征宏 凌
执行总监 

成都百裕制药股份有限公司 China

Baiyu , founded in 2005, is a pharmaceutical enterprise engaged in developing, manufacturing and distributing of high-quality pharmaceutical products and APIs. With about 1000 employees, Baiyu now has 6 subsidiaries including Golden Ginkgo Pharmaceutical Co., Ltd., Ginkgolide Pharmaceuticals Co., Ltd., Sunshine Ginkgo Agriculture Co.Ltd., Sichuan Yu Jian Pharmaceutical Co., Ltd. and Ginkgo Yukang Informatics Co.,Ltd., Ginkgo Yuda Pharmaceutical Co.,Ltd., et al.

Currently,we have 8 finished pharmaceutical products and 2 APIs on the market. Based on Quality-by-Design concept, our manufacturing sites strictly comply with cGMP and EU GMP. Ginkgolide injection, Enoxaparin sodium injection, Lansoprazole for injection are our main products.

Baiyu is growing fastly and has been awarded“National High-tech Enterprise”,“Sichuan Famous Brand”and“Enterprises with the most investment value in Chinese pharmaceutical industry”in 3 consecutive years.

The culture of kindness, Taiji and phoenix leads the way we behave and our vision is to constantly benefiting mankind to enjoy life-long well-being.

Nicky 吕
Lv 
Functionality

扬子江南京海陵 China

由扬子江药业集团2001年创建,为扬子江药业集团南京地区子公司,目前已发展为一家集科研、生产、营销于一体的国家高新技术企业,项目获批国家工程研究中心,江苏省院士工作站,建立了国际化研发体系,2015年成功入选南京市高端人才团队。
Looking for
Headquartner in China
Service Description
治疗产品 Therapeutic products
婧雅 易
BD总监 

新华海纳股权投资基金 China

成都新华海纳医疗创新股权投资中心(有限合伙)该支基金由新华瑞恒基金管理公司与雷宁博士等医疗领域专业投资团队共同发起。基金围绕创新医药、医疗器械、医疗服务领域中临床应用前景良好,市场空间巨大的早期企业,以及未来5年营业收入及净利润增长迅速,可能成为龙头企业或并购标的。其中,创新医药以早期大、小分子创新药物和海外引进创新药物为主要布局方向;医疗器械以天使轮/A轮微创外科和生物材料为重点关注对象;医疗服务领域将以高性能生物材料研发平台、医疗互联网平台和医疗人工智能平台为主。
Looking for
Headquartner in China
Service Description
项目投资: 疫苗、医美材料、高值耗材、创新药、CRO、实验动物平台、人工器官
庆一 陈
投资总监